Physician

Renuka Rajagopal, M.D

According to 2025 Medicare claims, Renuka Rajagopal, M.D (NPI: 1912326471) practices pulmonary disease in the Sumter, SC market, with the plurality of this provider's patient population coming from Sumter, SC. This provider's primary affiliated billing organization is PRISMA HEALTH MEDICAL GROUP-MIDLANDS (NPI: 1275988321; TIN: 471345819) and primary practice location at 29150-4971. Rajagopal is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Rajagopal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 518 traditional Medicare patients, billed 1,983 HCPCS/CPT codes, and received $115,662 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,718 prescription claims across 416 beneficiaries totaling $1,238,807 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 1,454 claims. Open Payments data shows 32 records totaling $781. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $4,359 to $1,238,807. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$58K$116K2021 Medicare payment: $26,311 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $56,895 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $71,743 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $115,662 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021107321$26,311
2022276969$56,895
20234381,612$71,743
20245181,983$115,662

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$619K$1.2M2015 Drug cost: $4,359 (USD; Tot_Drug_Cst)2016 Drug cost: $40,939 (USD; Tot_Drug_Cst)2017 Drug cost: $88,861 (USD; Tot_Drug_Cst)2018 Drug cost: $93,199 (USD; Tot_Drug_Cst)2019 Drug cost: $6,090 (USD; Tot_Drug_Cst)2021 Drug cost: $15,713 (USD; Tot_Drug_Cst)2022 Drug cost: $141,731 (USD; Tot_Drug_Cst)2023 Drug cost: $453,613 (USD; Tot_Drug_Cst)2024 Drug cost: $1,238,807 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R28$4,359
201676578$40,939
2017113905$88,861
20181191,256$93,199
20191536$6,090
2020N/RN/RN/R
20213292$15,713
2022116747$141,731
20232361,340$453,613
20244162,718$1,238,807

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$123K$247K2022 Medicare payment: $27,096 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $59,448 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $246,663 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/R49$27,096
2023106339$59,448
20243581,454$246,663

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more200317$134
94726Test to determine lung volumes using sensors285292$9
94060Test to measure expiratory airflow and volume changes before and after medication administration190198$8
94729Test to examine how well the lungs exchange gases291305$7
94010Test to measure expiratory airflow and volume110114$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OfevNintedanib Esylate21630$264,726
Dupixent PenDupilumab591,904$237,498
Breztri AerosphereBudesonide/Glycopyr/Formoterol29810,230$203,499
Trelegy ElliptaFluticasone/Umeclidin/Vilanter1725,760$118,583
Fasenra PenBenralizumab14532$69,354

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0483High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, eachY2192$91,197
E0466Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)Y1685$73,773
J7677Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgramNN/R31$23,663
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateY33241$20,764
J7606Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 microgramsNN/R28$4,096

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.32$781AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Renuka Rajagopal, M.D?

Tedicare shows public-source Medicare data for Renuka Rajagopal, M.D (NPI 1912326471), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Renuka Rajagopal, M.D have ACO affiliation data?

Renuka Rajagopal, M.D is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Renuka Rajagopal, M.D?

Renuka Rajagopal, M.D is linked to PRISMA HEALTH MEDICAL GROUP-MIDLANDS (billing NPI 1275988321) in the available physician profile data.

Does Renuka Rajagopal, M.D have Open Payments data?

Renuka Rajagopal, M.D has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.